JPL Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$920K Buy
767
+16
+2% +$16.3K 0.18% 82
2026
Q1
$690K Sell
751
-30
-4% -$30.4K 0.16% 83
2025
Q4
$839K Sell
781
-16
-2% -$15.3K 0.2% 84
2025
Q3
$608K Sell
797
-41
-5% -$30.5K 0.14% 90
2025
Q2
$653K Sell
838
-80
-9% -$62.2K 0.18% 86
2025
Q1
$758K Buy
918
+19
+2% +$15.8K 0.22% 80
2024
Q4
$694K Buy
+899
New +$744K 0.2% 80
2024
Q2
$709K Buy
783
+216
+38% +$173K 0.35% 71
2024
Q1
$441K Buy
567
+12
+2% +$8.54K 0.24% 81
2023
Q4
$324K Buy
+555
New +$324K 0.23% 86

Other funds holding LLY

JPL Wealth Management's LLY Position: Q2 2026 in Review

JPL Wealth Management increased its Eli Lilly (LLY) stake by 2.1% in Q2 2026, buying an estimated $16.3K and bringing the position to 767 shares worth $920K. The position accounts for 0.18% of the portfolio, ranked #82.

JPL Wealth Management first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • JPL Wealth Management held 767 shares of Eli Lilly worth $920K as of Q2 2026.
  • JPL Wealth Management bought 16 Eli Lilly shares in Q2 2026, an estimated $16.3K.
  • Eli Lilly made up 0.18% of JPL Wealth Management's portfolio in Q2 2026, its #82 holding.
  • JPL Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.